129 related articles for article (PubMed ID: 11461168)
1. Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia.
Yu PH
Med Hypotheses; 2001 Aug; 57(2):175-9. PubMed ID: 11461168
[TBL] [Abstract][Full Text] [Related]
2. The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease.
Jiang ZJ; Richardson JS; Yu PH
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):194-204. PubMed ID: 17971074
[TBL] [Abstract][Full Text] [Related]
3. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine.
Gubisne-Haberle D; Hill W; Kazachkov M; Richardson JS; Yu PH
J Pharmacol Exp Ther; 2004 Sep; 310(3):1125-32. PubMed ID: 15128865
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD.
Solé M; Miñano-Molina AJ; Unzeta M
Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560
[TBL] [Abstract][Full Text] [Related]
5. Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis.
Chen K; Maley J; Yu PH
J Neurochem; 2006 Dec; 99(5):1413-24. PubMed ID: 17074066
[TBL] [Abstract][Full Text] [Related]
6. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats.
Somfai GM; Knippel B; Ruzicska E; Stadler K; Tóth M; Salacz G; Magyar K; Somogyi A
Neurochem Int; 2006 Jun; 48(8):746-52. PubMed ID: 16524643
[TBL] [Abstract][Full Text] [Related]
7. Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging.
del Mar Hernandez M; Esteban M; Szabo P; Boada M; Unzeta M
Neurosci Lett; 2005 Aug 12-19; 384(1-2):183-7. PubMed ID: 15894424
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Ferrer I; Lizcano JM; Hernández M; Unzeta M
Neurosci Lett; 2002 Mar; 321(1-2):21-4. PubMed ID: 11872247
[TBL] [Abstract][Full Text] [Related]
9. Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease.
Unzeta M; Solé M; Boada M; Hernández M
J Neural Transm (Vienna); 2007; 114(6):857-62. PubMed ID: 17393059
[TBL] [Abstract][Full Text] [Related]
10. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation.
Yu PH; Lu LX; Fan H; Kazachkov M; Jiang ZJ; Jalkanen S; Stolen C
Am J Pathol; 2006 Mar; 168(3):718-26. PubMed ID: 16507887
[TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus.
Valente T; Gella A; Solé M; Durany N; Unzeta M
J Neurosci Res; 2012 Oct; 90(10):1989-96. PubMed ID: 22714978
[TBL] [Abstract][Full Text] [Related]
13. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
Yu PH; Wright S; Fan EH; Lun ZR; Gubisne-Harberle D
Biochim Biophys Acta; 2003 Apr; 1647(1-2):193-9. PubMed ID: 12686132
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
15. Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice.
Yu PH; Wang M; Fan H; Deng Y; Gubisne-Haberle D
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E634-41. PubMed ID: 14656718
[TBL] [Abstract][Full Text] [Related]
16. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
Stolen CM; Madanat R; Marti L; Kari S; Yegutkin GG; Sariola H; Zorzano A; Jalkanen S
FASEB J; 2004 Apr; 18(6):702-4. PubMed ID: 14977883
[TBL] [Abstract][Full Text] [Related]
17. SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.
Unzeta M; Hernàndez-Guillamon M; Sun P; Solé M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805974
[TBL] [Abstract][Full Text] [Related]
18. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet.
Yu PH; Wang M; Deng YL; Fan H; Shira-Bock L
Diabetologia; 2002 Sep; 45(9):1255-62. PubMed ID: 12242458
[TBL] [Abstract][Full Text] [Related]
19. Soluble semicarbazide sensitive amine oxidase (SSAO) catalysis induces apoptosis in vascular smooth muscle cells.
Hernandez M; Solé M; Boada M; Unzeta M
Biochim Biophys Acta; 2006 Feb; 1763(2):164-73. PubMed ID: 16448709
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review.
Obata T
Life Sci; 2006 Jun; 79(5):417-22. PubMed ID: 16487546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
